Our team and partners

SurvivX is currently supported by “Vroege Fase Financiering” from Oost NL (East Netherlands Development Agency), an agency that focusses its activities and projects on strengthening and stimulating the economy of the provinces of Gelderland and Overijssel, the Netherlands. Oost NL plays an important role in executing the economic policies of the Dutch government and the Provinces of Gelderland and Overijssel and its various city governments. To achieve this it is necessary to encourage a close cooperation between businesses, regional institutes, knowledge institutes, and intermediaries. Oost NL acts as a bridge between government, companies and knowledge institutes.

INCATE brings together translational and basic research, industry, experienced entrepreneurs and investors from across Europe to accelerate your innovation. INCATE does so by providing advice, community and funding. Our focus is on the development of new therapies, diagnostics and interventions that help reduce the prevalence and impact of Antimicrobial Resistance (AMR). SurvivX has recently been awarded a INCATE resident status.

The Centre for Cellular and Molecular Platforms (C-CAMP) is an initiative that is supported by Department of Biotechnology from the Government of India. They are a catalyst of cutting-edge research and innovation in the life sciences, and facilitate Bioscience Research and Entrepreneurship by providing Research, Development, Training and Services in state-of-the-art Technology Platforms. C-CAMP is of our key corporation partner in India for the development of SUR-101.

The core-technology from SurvivX, SUR-101 is the results of years of dedicated by years of studies by Professor Balachandran Ravindran from the Institute for Life Sciences (ILS) in India. The research activity of ILS focuses on basic, applied, translational and interdisciplinary focus areas, and are by 26 faculties and are supported by 150 research fellows, 25 post-doctoral fellows, and women scientists, as well as more than 100 project staff. Like C-CAMP, the administrative control of the institute is with the Department of Biotechnology from the Government of India.

We collaborate with by the 2 leading centers in sepsis research in the Netherlands. At Amsterdam UMC we collaborate with professor Tom van der Poll. The research headed by Tom van der Poll focuses on the immunology and immunotherapy of sepsis and has a strong translational character.

The premises of SurvivX are located on the campus of Radboud UMC in Nijmegen in the Eastern part of the Netherlands. Here we collaborate with professor Mihai Netea who is head of the Department of Experimental Medicine and specialized in infectious disease, immunology, and global health. Moreover, we work with professor Peter Pickkers at the department of Intensive Care of Radboud UMC. His research focuses on pharmacological modulation of the innate immune response in translational models and patients.